Are you familiar with menin inhibitors and their rationale for the treatment of KMT2A-rearranged acute myeloid leukemia (AML)? Are you up to date with relevant clinical trial data on menin inhibitors in AML released within the year? Through this interactive Booster Quiz, test your knowledge, competency, and confidence in decoding the mechanism of action and the latest data on new and emerging menin inhibitors for KMT2A-rearranged AML. This unique learning experience provides: Instant expert feedback on your answer selections Opportunity to see how well you do relative to your peers Downloadable summary with key supporting evidence and relevant practice tips
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/decoding-menin-inhibitors-acute-myeloid-leukemia-care
- Start Date: 2025-01-15 06:00:00
- End Date: 2025-01-15 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Syndax Pharmaceuticals - Amount: 24875.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest